UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality

The American journal of psychiatry, 2017-07, Vol.174 (7), p.640-648

2017

Volltextzugriff (PDF)

A Clinical Overview of Monoamine Oxidase Inhibitors: Pharmacological Profile, Efficacy, Safety/Tolerability, and Strategies for Successful Outcomes in the Management of Major Depressive Disorders

Psychiatric annals, 2014-11, Vol.44 (11), p.513-523

2014

Volltextzugriff (PDF)

Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances

The journal of clinical psychiatry, 2013-01, Vol.74 Suppl 2 (suppl 2), p.9-13

Zajecka, John M

2013

Volltextzugriff (PDF)

l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

The American journal of psychiatry, 2012-12, Vol.169 (12), p.1267-1274

2012

Volltextzugriff (PDF)

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Neuropsychopharmacology (New York, N.Y.), 2017-03, Vol.42 (4), p.844-853

2017

Volltextzugriff (PDF)

Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial

The journal of clinical psychiatry, 2014-08, Vol.75 (8), p.855-863

2014

Volltextzugriff (PDF)

Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs

The journal of clinical psychiatry, 2015-12, Vol.76 (12), p.1635

2015

Volltextzugriff (PDF)

Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study

The journal of clinical psychiatry, 2016-05, Vol.77 (5), p.654-660

2016

Volltextzugriff (PDF)

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

Neuropsychiatric disease and treatment, 2019-04, Vol.15, p.795-808

2019

Volltextzugriff (PDF)

Monoamine Oxidase Inhibitors: A Clinical Colloquy

Psychiatric annals, 2014-12, Vol.44 (12), p.577-588

2014

Volltextzugriff (PDF)

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder

The journal of clinical psychiatry, 2002-12, Vol.63 (12), p.1148-1155

2002

Volltextzugriff (PDF)

Evidence for the use of l-methylfolate combined with antidepressants in MDD

The journal of clinical psychiatry, 2011-08, Vol.72 (8), p.e25

2011

Volltextzugriff (PDF)

Augmentation strategies to increase antidepressant tolerability

The journal of clinical psychiatry, 2007, Vol.68 Suppl 10, p.23

Zajecka, John M

2007

Volltextzugriff (PDF)

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial

The journal of clinical psychiatry, 2006, Vol.67 (1), p.15-22

2006

Volltextzugriff (PDF)

Clinical issues in long-term treatment with antidepressants

The journal of clinical psychiatry, 2000, Vol.61 Suppl 2, p.20

Zajecka, J M

2000

Volltextzugriff (PDF)

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases

The journal of clinical psychiatry, 2007-08, Vol.68 (8), p.1246-1256

2007

Volltextzugriff (PDF)

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients

The journal of clinical psychiatry, 2001-01, Vol.62 (1), p.12-18

2001

Volltextzugriff (PDF)

Treating depression to remission

The journal of clinical psychiatry, 2003, Vol.64 Suppl 15, p.7

Zajecka, John M

2003

Volltextzugriff (PDF)

Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release

Journal of affective disorders, 2010-11, Vol.126 (3), p.420-429

2010

Volltextzugriff (PDF)

A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder

The journal of clinical psychiatry, 2012-12, Vol.73 (12), p.1541-1547

2012

Volltextzugriff (PDF)

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study

The journal of clinical psychiatry, 2007-07, Vol.68 (7), p.1014-1023

2007

Volltextzugriff (PDF)

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

Biological psychiatry (1969), 2007-12, Vol.62 (12), p.1371-1379

2007

Volltextzugriff (PDF)

SNRIs in the management of acute major depressive disorder

The journal of clinical psychiatry, 2004, Vol.65 Suppl 17, p.11

2004

Volltextzugriff (PDF)

A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder

The journal of clinical psychiatry, 2006-11, Vol.67 (11), p.1674-1681

2006

Volltextzugriff (PDF)

Oral divalproex sodium loading for adolescent outpatients with acute mania/hypomania: a report of 2 cases

The journal of clinical psychiatry, 2008-06, Vol.69 (6), p.1016-1018

2008

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(70)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(57)
Science & Technology
(57)
Psychiatry
(55)
Humans
(53)
Male
(40)
Female
(39)
Adult
(35)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Treatment Outcome
(28)
Psychology. Psychoanalysis. Psychiatry
(27)
Middle Aged
(25)
Double-Blind Method
(24)
Pharmacology. Drug Treatments
(24)
Psychology
(24)
Psychology, Clinical
(24)
Social Sciences
(24)
Psychopharmacology
(22)
Neuropharmacology
(21)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality

A Clinical Overview of Monoamine Oxidase Inhibitors: Pharmacological Profile, Efficacy, Safety/Tolerability, and Strategies for Successful Outcomes in the Management of Major Depressive Disorders

Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances

l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial

Association of obesity and inflammatory marker levels on treatment outcome: results from a double-blind, randomized study of adjunctive L-methylfolate calcium in patients with MDD who are inadequate responders to SSRIs

Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: a 12-month, open-label study following a placebo-controlled acute study

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

Monoamine Oxidase Inhibitors: A Clinical Colloquy

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder

Evidence for the use of l-methylfolate combined with antidepressants in MDD

Augmentation strategies to increase antidepressant tolerability

High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial

Clinical issues in long-term treatment with antidepressants

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients

Treating depression to remission

Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release

A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder

Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

SNRIs in the management of acute major depressive disorder

A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder

Oral divalproex sodium loading for adolescent outpatients with acute mania/hypomania: a report of 2 cases

Suchergebnisse filtern